AKTX
Akari Therapeutics
AKTX
AKTX
14 hedge funds and large institutions have $2.93M invested in Akari Therapeutics in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$382K | |
| 2 | +$18.8K | |
| 3 | +$3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3K |
| 5 |
Morgan Stanley
New York
|
+$189 |
Top Sellers
| 1 | -$88K | |
| 2 | -$55K | |
| 3 | -$18K | |
| 4 |
Renaissance Technologies
New York
|
-$1.81K |